​

BeOne Medicines (ONC) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

BeOne Medicines Revenue Highlights


Latest Revenue (Y)

$5.34B

Latest Revenue (Q)

$1.89B

Main Segment (Y)

Product

Main Geography (Y)

UNITED STATES

BeOne Medicines Revenue by Period


BeOne Medicines Revenue by Year

DateRevenueChange
2025-12-31$5.34B40.23%
2024-12-31$3.81B54.96%
2023-12-31$2.46B73.65%
2022-12-31$1.42B20.37%
2021-12-31$1.18B280.83%
2020-12-31$308.87M-27.87%
2019-12-31$428.21M116.03%
2018-12-31$198.22M-16.85%
2017-12-31$238.39M22179.16%
2016-12-31$1.07M-87.86%
2015-12-31$8.82M-32.37%
2014-12-31$13.04M16.93%
2013-12-31$11.15M-

BeOne Medicines generated $5.34B in revenue during NA 2025, up 40.23% compared to the previous quarter, and up 1729.84% compared to the same period a year ago.

BeOne Medicines Revenue by Quarter

DateRevenueChange
2026-09-30$1.89B10.83%
2026-06-30$1.71B12.66%
2026-03-31$1.51B1.02%
2025-12-31$1.50B6.08%
2025-09-30$1.41B7.37%
2025-06-30$1.32B17.72%
2025-03-31$1.12B-0.93%
2024-12-31$1.13B12.60%
2024-09-30$1.00B7.80%
2024-06-30$929.17M23.62%
2024-03-31$751.65M18.48%
2023-12-31$634.41M-18.80%
2023-09-30$781.31M31.25%
2023-06-30$595.26M32.93%
2023-03-31$447.80M17.81%
2022-12-31$380.10M-1.94%
2022-09-30$387.63M13.48%
2022-06-30$341.57M11.40%
2022-03-31$306.63M43.30%
2021-12-31$213.98M3.65%
2021-09-30$206.44M37.63%
2021-06-30$149.99M-75.24%
2021-03-31$605.87M505.27%
2020-12-31$100.10M9.90%
2020-09-30$91.08M38.77%
2020-06-30$65.64M26.08%
2020-03-31$52.06M-8.50%
2019-12-31$56.89M13.46%
2019-09-30$50.14M-79.40%
2019-06-30$243.35M212.65%
2019-03-31$77.83M32.66%
2018-12-31$58.67M8.24%
2018-09-30$54.20M2.65%
2018-06-30$52.80M62.25%
2018-03-31$32.54M79.07%
2017-12-31$18.17M-91.75%
2017-09-30$220.21M100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30--100.00%
2016-06-30$393.00K-41.95%
2016-03-31$677.00K-85.52%
2015-12-31$4.68M238.91%
2015-09-30$1.38M-
2015-06-30$1.38M0.07%
2015-03-31$1.38M-0.14%
2014-12-31$1.38M-78.74%
2014-09-30$6.50M151.88%
2014-06-30$2.58M-
2014-03-31$2.58M-

BeOne Medicines generated $1.89B in revenue during Q3 2026, up 10.83% compared to the previous quarter, and up 143.68% compared to the same period a year ago.

BeOne Medicines Revenue Breakdown


BeOne Medicines Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25
Collaboration$60.97M
Product$6.73B

BeOne Medicines's latest annual revenue breakdown by segment (product or service), as of Dec 25: Product (99.10%), and Collaboration (0.90%).

Quarterly Revenue by Product

Product/ServiceSep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25
Product$2.44B$2.21B$1.89B$1.90B$1.77B$1.66B$1.40B
Collaboration---$39.00M$13.22M$8.75M-

BeOne Medicines's latest quarterly revenue breakdown by segment (product or service), as of Sep 26: Product (100.00%).

BeOne Medicines Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 25
CHINA$1.68B
UNITED STATES$2.88B
Europe$611.37M

BeOne Medicines's latest annual revenue breakdown by geography, as of Dec 25: UNITED STATES (55.70%), CHINA (32.48%), and Europe (11.82%).

Quarterly Revenue by Country

CountrySep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25
CHINA$536.37M$506.02M$471.97M$407.13M$439.88M$432.92M$399.59M
UNITED STATES$1.03B$914.21M$782.25M$863.83M$754.86M$694.43M$567.21M
Europe$239.56M$208.75M$194.00M$173.85M$166.58M$152.38M$118.55M
All Other Countries Except China And United States Of America-$76.09M$65.21M$50.97M$35.56M$31.92M-

BeOne Medicines's latest quarterly revenue breakdown by geography, as of Sep 26: UNITED STATES (56.98%), CHINA (29.73%), and Europe (13.28%).

ONC Revenue FAQ


What is BeOne Medicines’s yearly revenue?

BeOne Medicines's yearly revenue for 2025 was $5.34B, representing an increase of 40.23% compared to 2024. The company's yearly revenue for 2024 was $3.81B, representing an increase of 54.96% compared to 2023. ONC's yearly revenue for 2023 was $2.46B, representing an increase of 73.65% compared to 2022.

What is BeOne Medicines’s quarterly revenue?

BeOne Medicines's quarterly revenue for Q3 2026 was $1.89B, a 10.83% increase from the previous quarter (Q2 2026), and a 33.81% increase year-over-year (Q3 2025). The company's quarterly revenue for Q2 2026 was $1.71B, a 12.66% increase from the previous quarter (Q1 2026), and a 29.63% increase year-over-year (Q2 2025). ONC's quarterly revenue for Q1 2026 was $1.51B, a 1.02% increase from the previous quarter (Q4 2025), and a 35.46% increase year-over-year (Q1 2025).

What is BeOne Medicines’s revenue growth rate?

BeOne Medicines's revenue growth rate for the last 3 years (2023-2025) was 117.30%, and for the last 5 years (2021-2025) was 354.23%.

What are BeOne Medicines’s revenue streams?

BeOne Medicines's revenue streams in c 25 are Collaboration, and Product. Collaboration generated $60.97M in revenue, accounting 0.90% of the company's total revenue Product generated $6.73B in revenue, accounting 99.10% of the company's total revenue

What is BeOne Medicines’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of BeOne Medicines was Product. This segment made a revenue of $6.73B, representing 99.10% of the company's total revenue.